The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The effects of physical exercise on fatty liver disease.
Open accessAbstract
The increasing prevalence of obesity has made nonalcoholic fatty liver disease (NAFLD) the most common chronic liver disease. As a consequence, NAFLD and especially its inflammatory form nonalcoholic steatohepatitis (NASH) are the fastest increasing etiology of end-stage liver disease and hepatocellular carcinoma. Physical inactivity is related to the severity of fatty liver disease irrespective of body weight, supporting the hypothesis that increasing physical activity through exercise can improve fatty liver disease. This review summarizes the evidence for the effects of physical exercise on NAFLD and NASH. Several clinical trials have shown that both aerobic and resistance exercise reduce the hepatic fat content. From clinical and basic scientific studies, it is evident that exercise affects fatty liver disease through various pathways. Improved peripheral insulin resistance reduces the excess delivery of free fatty acids and glucose for free fatty acid synthesis to the liver. In the liver, exercise increases fatty acid oxidation, decreases fatty acid synthesis, and prevents mitochondrial and hepatocellular damage through a reduction of the release of damage-associated molecular patterns. In conclusion, physical exercise is a proven therapeutic strategy to improve fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Physical activity has proven to be an effective intervention for treating and preventing NAFLD”
From Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution (2021) · cites this paper as van der Windt et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cintra, D. E., Ropelle, E. R., Vitto, M. F., Luciano, T. F., Souza, D. R., Engelmann, J., Marques, S. D. O., Lira, F. S., Pinho, R. A., Pauli, J. R., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.002 · Cited by 34
Retracted2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,854
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,182
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Cited by
Sorted by citations
Sheka, A. C., Adeyi, O. A., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,421
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 452
Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1571114 · Cited by 386
Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit
McGee, S. L., & Hargreaves, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0377-1 · Cited by 226
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
Abenavoli, L., Boccuto, L., Federico, A., Dallio, M., Loguercio, C., Renzo, L. D., & LORENZO, A. D. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173011 · Cited by 123
Fernández, T., Viñuela, M., Vidal, C., & Barrera, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263931 · Cited by 117
Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K., & Jensen, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.737709 · Cited by 112
Weinstein, G., Davis‐Plourde, K. L., Himali, J. J., Zelber‐Sagi, S., Beiser, A., & Seshadri, S. S. (2019) · Liver International · doi:10.1111/liv.14161 · Cited by 108
Babu, A. F., Csader, S., Lok, J., Gómez-Gallego, C., Hanhineva, K., El-Nezami, H. S., & Schwab, U. (2021) · Nutrients · doi:10.3390/nu13093135 · Cited by 102
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH
Fredrickson, G., Barrow, F., DIETSCHE, K. B., Parthiban, P., Khan, S. M., Robert, S., Demirchian, M., Rhoades, H., Wang, H., Adeyi, O. A., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101270 · Cited by 91
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Torre, S. D. (2021) · Cells · doi:10.3390/cells10092502 · Cited by 91
Qiu, Y., Gan, M., Wang, X., Liao, T., Chen, Q., Lei, Y., Chen, L., Wang, J., Zhao, Y., Niu, L., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127042 · Cited by 85
Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis
Chen, M., Xie, Y., Gong, S., Wang, Y., Yu, H., Zhou, T., Huang, F., Guo, X., Zhang, H., Huang, R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105849 · Cited by 81
Oh, S., Tsujimoto, T., Kim, B., Uchida, F., Suzuki, H., Iizumi, S., Isobe, T., Sakae, T., Tanaka, K., & Shoda, J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100253 · Cited by 77
Schneider, C. V., Zandvakili, I., Thaiss, C. A., & Schneider, K. M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100263 · Cited by 73
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Riazi, K., Swain, M. G., Congly, S. E., Kaplan, G. G., & Shaheen, A. A. (2022) · Nutrients · doi:10.3390/nu14214556 · Cited by 75
Wearable accelerometer-derived physical activity and incident disease
Khurshid, S., Weng, L.-C., Nauffal, V., Pirruccello, J. P., Venn, R. A., Al-Alusi, M. A., Benjamin, E. J., Ellinor, P. T., & Lubitz, S. A. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00676-9 · Cited by 63
Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Baker, P. R., & Friedman, J. E. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120846 · Cited by 64
Ju, U.-I., Jeong, D., Seo, J., Park, J. B., Park, J., Suh, K., Kim, J. B., & Chun, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2472-6 · Cited by 60
Kong, J., Xie, Y., Fan, R., Wang, Q., Luo, Y., & Dong, P. (2025) · European journal of medical research · doi:10.1186/s40001-025-02751-9 · Cited by 74
Simon, T. G., Kim, M. N., Luo, X., Yang, W., Ma, Y., Chong, D. Q., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., Chung, R. T., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.022 · Cited by 57
Nonalcoholic fatty liver disease: lifestyle and quality of life
Vachliotis, I. D., Goulas, A., Papaioannidou, P., & Pοlyzos, S. A. (2021) · HORMONES · doi:10.1007/s42000-021-00339-6 · Cited by 59
Marques, E., Pfohl, M., Auclair, A., Jamwal, R., Barlock, B. J., Sammoura, F. M., Goedken, M. J., Akhlaghi, F., & Slitt, A. L. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115250 · Cited by 59
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 60
Exercise regulates lipid droplet dynamics in normal and fatty liver
la Fuente, F. P.-D., Quezada, L., Sepúlveda, C., Monsalves‐Álvarez, M., Rodríguez, J. M., Sacristán, C., Chiong, M., Llanos, M. N., Espinosa, A., & Troncoso, R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158519 · Cited by 54
Ni, Y., Ni, L., Zhuge, F., & Fu, Z. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000375 · Cited by 53
Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 55
Dua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 53
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0239 · Cited by 52
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Jarmakiewicz-Czaja, S., Sokal-Dembowska, A., Pardak, P., & Filip, R. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/4344905 · Cited by 48
Li, S.-W., Takahara, T., Que, W., Fujino, M., Guo, W.-Z., Hirano, S., Ye, L., & Li, X. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00158.2020 · Cited by 47
Khalifa, O., Al-Akl, N. S., Errafii, K., & Arredouani, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-06143-5 · Cited by 43
The Global Epidemic of Metabolic Fatty Liver Disease
Lee, E. C. Z., Anand, V. V., Razavi, A. C., Alebna, P. L., Muthiah, M. D., Siddiqui, M. S., Chew, N., & Mehta, A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02025-6 · Cited by 43
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
Zhang, J.-Z., Cai, J., Yu, Y., She, Z., & Li, H. (2019) · Gene Expression · doi:10.3727/105221619x15553433838609 · Cited by 42
Yang, J., Sáinź, N., Félix‐Soriano, E., Gil‐Iturbe, E., Castilla‐Madrigal, R., Fernández‐Galilea, M., Martínez, J. A., & Moreno-Aliaga, M. J. (2021) · Nutrients · doi:10.3390/nu13020501 · Cited by 40
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases
Hernández-Ceballos, W., Córdova‐Gallardo, J., & Méndez‐Sánchez, N. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00131 · Cited by 40
Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
Smeuninx, B., Boslem, E., & Febbraio, M. A. (2020) · Cancers · doi:10.3390/cancers12071714 · Cited by 39
Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?
Bonsembiante, L., Targher, G., & Maffeis, C. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00928-z · Cited by 40
Xu, J., Wei, Y., Huang, Y., & Wei, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07702 · Cited by 38
Sanchez, P. B. M., Krizanac, M., Weiskirchen, R., & Asimakopoulos, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105284 · Cited by 36
Huang, W.-C., Xu, J.-W., Li, S., Ng, X. E., & Tung, Y. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00644-w · Cited by 37
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Devasia, A. G., Ramasamy, A., & Leo, C. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041778 · Cited by 43
Sundbaum, J. K., Eriksson, N., Hallberg, P., Lehto, N., Wadelius, M., & Baecklund, E. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13576 · Cited by 36
Słomko, J., Zalewska, M., Niemiro, W., Kujawski, S., Słupski, M., Januszko‐Giergielewicz, B., Zawadka‐Kunikowska, M., Newton, J. L., Hodges, L. D., Kubica, J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081659 · Cited by 35
Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review
Abunofal, O., & Mohan, C. (2022) · Medicines · doi:10.3390/medicines9030020 · Cited by 35
Edmunds, K., Tuffaha, H., Scuffham, P., Galvao, D. A., & Newton, R. U. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05637-0 · Cited by 38
Oligonucleotide therapies for nonalcoholic steatohepatitis
Li, S., Xiong, F., Zhang, S., Liu, J., Gao, G., Xie, J. H., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102184 · Cited by 32
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Vidal‐Cevallos, P., Sorroza-Martínez, A. P., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084397 · Cited by 32
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
Houttu, V., Boulund, U., Grefhorst, A., Soeters, M. R., Pinto‐Sietsma, S., Nieuwdorp, M., & Holleboom, A. G. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820941745 · Cited by 32
Aerobic Exercise and Metabolic Syndrome: The Role of Sympathetic Activity and the Redox System
Monda, V., Sessa, F., Ruberto, M., Carotenuto, M., Marsala, G., Monda, M., Cambria, M. T., Astuto, M., Distefano, A., & Messina, G. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s257687 · Cited by 29
Karjoo, S., Auriemma, A., Fraker, T. R., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100027 · Cited by 33
Hoseini, Z., Behpoor, N., & Hoseini, R. (2020) · Hepatitis Monthly · doi:10.5812/hepatmon.96437 · Cited by 29
Drapkina, O. M., Elkina, A. Y., Sheptulina, A. F., & Kiselev, A. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098445 · Cited by 30
Mouskeftara, T., Deda, O., Papadopoulos, G., Chatzigeorgiou, A., & Gika, H. (2024) · Molecules · doi:10.3390/molecules29071494 · Cited by 27
Liu, M., Ye, Z., Zhang, Y., He, P., Zhou, C., Yang, S., Zhang, Y., Gan, X., & Qin, X. (2024) · BMC Medicine · doi:10.1186/s12916-024-03618-2 · Cited by 28
Clemente‐Suárez, V. J., Rubio-Zarapuz, A., Belinchón-deMiguel, P., Beltrán-Velasco, A. I., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2024) · Cells · doi:10.3390/cells13231940 · Cited by 30
Gharaibeh, N. E., Rahhal, M.-N., Rahimi, L., & Ismail‐Beigi, F. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s212715 · Cited by 27
Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment
Chen, M., Cai, J., Yu, Y., She, Z., & Li, H. (2019) · Gene Expression · doi:10.3727/105221619x15536120524171 · Cited by 26
Conserved multi-tissue transcriptomic adaptations to exercise training in humans and mice
Moore, T. M., Lee-Ødegård, S., Olsén, T., Morselli, M., Strumwasser, A. R., Lin, A. J., Zhou, Z., Abrishami, A. D., Garcia, S. M., Bribiesca, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112499 · Cited by 27
Catanzaro, R., SELVAGGIO, F., Sciuto, M., Zanoli, L., Yazdani, A., He, F., & Marotta, F. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02818-x · Cited by 25
Ntamo, Y., Ziqubu, K., Chellan, N., Nkambule, B. B., Nyambuya, T. M., Mazibuko-Mbeje, S. E., Gabuza, K., Orlando, P., Tiano, L., & Dludla, P. V. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112638 · Cited by 25
Combined effects of lifestyle risk factors on fatty liver index
Nivukoski, U., Niemelä, M., Bloigu, A. H., Bloigu, R., Aalto, M., Laatikainen, T. K., & Niemelä, O. J. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01270-7 · Cited by 24
Gunadi, J. W., Tarawan, V. M., Ray, H. R. D., Wahyudianingsih, R., Lucretia, T., Tanuwijaya, F., Lesmana, R., Supratman, U., & Setiawan, I. B. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03874 · Cited by 24
Ageing and Obesity Shared Patterns: From Molecular Pathogenesis to Epigenetics
Ghanemi, A., Yoshioka, M., & St‐Amand, J. (2021) · Diseases · doi:10.3390/diseases9040087 · Cited by 26
Lee, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238943 · Cited by 24
Sun, P., Zeng, Q., Cheng, D., Zhang, K., Zheng, J., Liu, Y., Yuan, Y., & Tang, Y. (2018) · Hepatology · doi:10.1002/hep.30075 · Cited by 23
Ghamarchehreh, M. E., Shamsoddini, A., & Alavian, S. M. (2019) · Gastroenterology and hepatology from bed to bench. · Cited by 22
Lin, G., Zhang, X., Tian, H., Jin, X., Li, D., Wang, N., Jing, S., Xue, W., Zeng, Z., & Li, Y. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03351-w · Cited by 22
Henkel, J., Buchheim-Dieckow, K., Castro, J. P., Laeger, T., Wardelmann, K., Kleinridders, A., Jöhrens, K., & Püschel, G. P. (2019) · Nutrients · doi:10.3390/nu11112709 · Cited by 23
Ayyadurai, V. A. S., Deonikar, P., & Fields, C. (2023) · Nutrients · doi:10.3390/nu15030733 · Cited by 21
The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Zhang, T., Nie, Y., & Wang, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121943 · Cited by 21
Prabhakar, T., Prasad, M., Kumar, G., Kaushal, K., Shenoy, P. S., Dubey, S., & Sarin, S. K. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17892 · Cited by 21
Witayavanitkul, N., Werawatganon, D., Chayanupatkul, M., Klaikeaw, N., Sanguanrungsirikul, S., & Siriviriyakul, P. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02962-z · Cited by 19
Tas, E., Landes, R. D., Diaz, E. C., Bai, S., Ou, X., Buchmann, R. F., Na, X., Muzumdar, R. H., Børsheim, E., & Dranoff, J. A. (2023) · Obesity · doi:10.1002/oby.23887 · Cited by 21
Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD
Gabbia, D., & Martin, S. D. (2023) · Biology · doi:10.3390/biology12121471 · Cited by 19
Physical Activity and Risk of Hepatocellular Carcinoma Among U.S. Men and Women
Luo, X., Yang, W., Ma, Y., Simon, T. G., Meyerhardt, J. A., Chan, A. T., Giovannucci, E. L., & Zhang, X. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0447 · Cited by 18
Moderate-Intensity Exercise and Musical Co-Treatment Decreased the Circulating Level of Betatrophin
Susanto, H., Taufiq, A., Sugiharto, Merawati, D., Badu, K. M., Purnomo, J. D. T., & Handaya, A. Y. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3098261 · Cited by 18
Vivero, A., Manuel Ruz, O., Rivera, M., Miranda, K., Sacristán, C., Espinosa, A., Codoceo, J., Inostroza, J., Vásquez, K. Y., Pérez, Á., et al. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02324-3 · Cited by 18
Rao, A., Clayton, P., & Briskey, D. R. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12936 · Cited by 17
Nemati, S., Tadıbı, V., & Hoseini, R. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00538-3 · Cited by 18
Hong, F., Liu, Y., Lebaka, V. R., Mohammed, A., Ye, W., Chen, B., & Korivi, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.894044 · Cited by 18
Gupta, A., Patil, N. S., Mohapatra, N. R., Benjamin, J., Thapar, S., Kumar, A., Rastogi, A., & Pamecha, V. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005836 · Cited by 18
Physical exercise in liver diseases
Zhang, Y., Cao, C., Li, C., Witt, R. G., Huang, H., Tsung, A., & Zhang, H. (2024) · Hepatology · doi:10.1097/hep.0000000000000941 · Cited by 21
Cernea, S., & Onișor, D. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i2.286 · Cited by 18
Hao, X., Song, H., Su, X. Y., Li, J., Ye, Y., Wang, C., Xu, X. D., Pang, G., Liu, W., Li, Z., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2464223 · Cited by 18
The Role of Hydrogen Sulfide Regulation of Autophagy in Liver Disorders
Lü, X., Ding, Y., Liu, H., Sun, M., Chen, C., Yang, Y., & Wang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074035 · Cited by 18
Ciałowicz, M., Woźniewski, M., Murawska‐Ciałowicz, E., & Dzięgiel, P. (2025) · Cells · doi:10.3390/cells14161228 · Cited by 17
Abdelbasset, W. K., ELSAYED, S. H., Nambi, G. S., Alrawaili, S. M., Elnegamy, T. E., Khalil, M. A., Tantawy, S. A., Soliman, G. S., Ibrahim, A. A., & Kamel, D. M. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1923575 · Cited by 17
RetractedWang, G., Yu, Y., Cai, W., Batista, T. M., Suk, S., Noh, H. L., Hirshman, M. F., Nigro, P., Li, M. E., Softic, S., et al. (2020) · Diabetes · doi:10.2337/db20-0439 · Cited by 16
Aubin, C. R. S., Fisher, A., Hernández, J. A. F., Broderick, T. L., & Al‐Nakkash, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s358256 · Cited by 16
Farrugia, M. A., Garf, S. L., Chierici, A. P., Piche, T., Gual, P., Iannelli, A., & Anty, R. (2023) · Metabolites · doi:10.3390/metabo13030330 · Cited by 16
Deng, D., Lin, X., Liu, Y., Li, C., Jiang, Q., Shi, J., Feng, S., & Lin, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02565-y · Cited by 15
Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
Janota, B., Szczepańska, E., Adamek, B., & Janczewska, E. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i5.641 · Cited by 15
Pan, Y., Zhang, Y., Ouyang, H., Gong, T., Zhang, Z., Cao, X., & Fu, Y. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00612 · Cited by 15
Effects of low and moderate treadmill exercise on liver of d ‐galactose‐exposed aging rat model
Wasityastuti, W., Habib, N. A., Sari, D. C. R., & Arfian, N. (2019) · Physiological Reports · doi:10.14814/phy2.14279 · Cited by 16
González, A., Valero‐Breton, M., Huerta-Salgado, C., Achiardi, O. A., Simón, F., & Cabello‐Verrugio, C. (2021) · European Journal of Translational Myology · doi:10.4081/ejtm.2021.9630 · Cited by 28
“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 14
Effects of Environmental Enrichments on Welfare and Hepatic Metabolic Regulation of Broiler Chickens
Kang, S. W., Christensen, K. D., Kidd, M. T., & Orlowski, S. (2024) · Animals · doi:10.3390/ani14040557 · Cited by 15
Medeiros, D. G., Ferreira, L. F., Lamp, J. D. S., & da Rosa, L. H. T. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002887 · Cited by 15
Effect of endurance exercise training on liver gene expression in male and female mice
Melo, L., Tilmant, K., Hagar, A., & Klaunig, J. E. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0379 · Cited by 13
Metadata
- Authors
- van der Windt, D. J., Sud, V., Zhang, H., Tsung, A., & Huang, H.
- Affiliations
- Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
- University of Pittsburgh Medical Center (US)
- Venue
- Gene Expression
- Publisher
- Xia & He Publishing
- Published
- 2018-05-18
- Volume
- 18
- Issue
- 2
- Pages
- 89-101
- ISSN
- 1052-2166 (ISSN-L)
- PMC
- PMC5954622
- OpenAlex
- W2774108532
- Cited by
- 294
- References
- 114
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 40 · 2023: 39 · 2022: 36 · 2021: 61 · 2020: 42 · 2019: 17 · 2018: 3
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gene Expression (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA214865)
- National Institute of Allergy and Infectious Diseases (T32AI074490)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- physical activity, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, aerobic exercise, resistance training, hepatic fat content, insulin resistance, fatty acid oxidation, mitochondrial damage, hepatocyte injury, damage-associated molecular patterns, obesity, end-stage liver disease, hepatocellular carcinoma
- MeSH terms
- Animals, Energy Metabolism, Exercise Therapy, Humans, Insulin, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
